$VRTX
Vertex Pharmaceuticals Incorporated
PRICE
$225.25 ▼-0.133%
Extented Hours
VOLUME
2,242,187
DAY RANGE
224.39 - 227.6
52 WEEK
199.77 - 303.1
Echofin Members Consensus
Key Metrics
Market Cap
58.65 B
Beta
0.85
Avg. Volume
1.55 M
Shares Outstanding
260.04 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
CEO: Jeffrey Leiden
Website: https://www.vrtx.com/
HQ: 50 Northern Ave Boston, 02210-1862 Massachusetts
Related News
-
Vertex Pharmaceuticals Target Price $300 - Live Trading News
13 Jan 2021, 16:27 -
STAT+: Vertex Pharma taking more aggressive M&A stance, flush with cash from cystic fibrosis drugs
11 Jan 2021, 16:33 -
Vertex to Present at the J.P. Morgan Healthcare Conference on January 11 | Vertex Pharmaceuticals (Vertex Pharmaceuticals) | CompanyNewsHQ
07 Jan 2021, 19:39 -
Vertex to Present at the J.P. Morgan Healthcare Conference on January 11
07 Jan 2021, 14:01 -
RBC Capital Stick to Their Buy Rating for Vertex Pharmaceuticals
10 Dec 2020, 01:57